| prevalence of hepatitis c virus genotypes in mexican patients. | worldwide hcv studies have documented its large genetic variability; hcv has major genetic groups called genotypes that are designated from 1 to 6, as well as > 50 subtypes. this is very important considering that treatment response varies according to genotype. the purpose of this trial was to ascertain prevalence of hcv genotypes in a group of patients from 10 states in mexico. | 2007 | 18595321 |
| hepatitis c virus infection in blood donors from the state of puebla, mexico. | worldwide, 130 million persons are estimated to be infected with hcv. puebla is the mexican state with the highest mortality due to hepatic cirrhosis. therefore, it is imperative to obtain epidemiological data on hcv infection in asymptomatic people of this region. the objective of present study was to analyze the prevalence of antibodies and genotypes of hepatitis c virus (hcv) in blood donors from puebla, mexico. | 2010 | 20100349 |
| [heterogeneous distribution of the prevalence of anti-trypanosoma cruzi antibodies among blood donors in the state of puebla, mexico]. | to determine the seroprevalence and associated factors, of antibodies against trypanosoma cruzi (t. cruzi ab) among blood donors living in rural and suburban areas and risk regions. | 2005 | 15889637 |
| hepatitis c virus infection in patients and family members attending two primary care clinics in puebla, mexico. | approximately 180 million persons (~2.8%) globally are estimated to be infected by hepatitis c virus (hcv). hcv prevalence in mexico has been estimated to be between 1.2 and 1.4%. the aim of present work was to determine the prevalence of hcv infection in patients and family members attending two primary care clinics in puebla, mexico. | 2014 | 25332260 |